Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders

Author： Fasching Patrizia Stradner Martin Graninger Winfried Dejaco Christian Fessler Johannes

Publisher： MDPI

E-ISSN： 1420-3049|22|1|134-134

ISSN： 1420-3049

Source： Molecules, Vol.22, Iss.1, 2017-01, pp. : 134-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Balance of Th17 versus Treg Cells in Autoimmunity

By Lee Gap Ryol

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 730-730

MDPI

Access to resources Recommend Favorite

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases

By Owaga Eddy Hsieh Rong-Hong Mugendi Beatrice Masuku Sakhile Shih Chun-Kuang Chang Jung-Su

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 20841-20858

MDPI

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Ghrelin Pathway

By Colldén Gustav Tschöp Matthias H. Müller Timo D.

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 798-798

MDPI

Access to resources Recommend Favorite

Th17/Treg Cells Imbalance and GITRL Profile in Patients with Hashimoto’s Thyroiditis

By Liu Yingzhao Tang Xinyi Tian Jie Zhu Chenlu Peng Huiyong Rui Ke Wang Yungang Mao Chaoming Ma Jie Lu Liwei Xu Huaxi Wang Shengjun

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-11 ,pp. : 21674-21686

MDPI

Access to resources Recommend Favorite

The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting

By Saito Ryoko Miki Yasuhiro Ishida Naoya Inoue Chihiro Kobayashi Masayuki Hata Shuko Yamada-Okabe Hisafumi Okada Yoshinori Sasano Hironobu

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 609-609

MDPI

Access to resources Recommend Favorite